NDAINTRAVENOUSINJECTABLE
Approved
Jul 2001
Lifecycle
Peak
Competitive Pressure
0/100
Mechanism of Action
Ultrasound Contrast Activity
Pharmacologic Class:
Contrast Agent for Ultrasound Imaging
Loss of Exclusivity
LOE Date
May 4, 2037
136 months away
Patent Expiry
May 4, 2037